Therapeutic agent for amyotrophic lateral sclerosis

Details Therapeutic agent for amyotrophic lateral sclerosis Therapeutic agent for amyotrophic lateral sclerosis

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61K 31/415 (2006.01) A61K 31/426 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2658342

Disclosed is a novel therapeutic agent for amyotrophic lateral sclerosis. The therapeutic agent comprises a compound which has an inhibitory effect on xanthine dehydrogenase and cannot act as a substrate for purine salvage pathway.

La présente invention concerne un nouvel agent thérapeutique destiné à traiter la sclérose latérale amyotrophique. L'agent thérapeutique contient un composé qui produit un effet inhibiteur sur la xanthine déshydrogénase et ne peut pas servir de substrat pour la voie de récupération de la purine.

Affiliated with

Also associated with

Rating

Therapeutic agent for amyotrophic lateral sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for amyotrophic lateral sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for amyotrophic lateral sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1429880